Facebook
Twitter
Telegram
Fehler meldenPanbela Therapeutics Gewinn / Verlust 2011-2024 | PBLA
Gewinn / Verlust Jährlich Panbela Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
120 K | 549 | 506 K | 31.7 M | - | - | - | - | - | - | - | - | - |
Anteile |
109 K | 845 | 293 K | 5.7 M | - | - | - | - | - | - | - | - | - |
Kurshistorie |
1.1 | 0.65 | 1.73 | 3.56 | 4.2 | 3.5 | 10 | - | - | - | - | - | - |
Nettogewinn |
-25.3 M | -34.9 M | -10.1 M | -4.77 M | -6.2 M | -5.9 M | -10.4 M | -5.11 M | -4.93 M | -107 K | -212 K | 247 K | -138 K |
Umsatz |
- | - | - | - | - | - | - | - | - | 1.36 M | 974 K | 1.23 M | 700 K |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | 595 K | 558 K | 692 K | 551 K |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | 762 K | 415 K | 541 K | 149 K |
Betriebsergebnis |
-25.6 M | -34.1 M | -10 M | -5.75 M | -4.32 M | -3.89 M | -6.02 M | -5.17 M | -5.44 M | -3.44 M | -194 K | 283 K | -105 K |
Zinsaufwendungen |
317 K | 288 K | 12 K | 17 K | 2.19 M | 1.81 M | 1.62 M | 180 K | 183 K | 184 K | 35.9 K | 36.1 K | 34.3 K |
EBITDA |
-25.6 M | -34.1 M | -10 M | -5.15 M | -4.42 M | -4.34 M | -6.02 M | -5.17 M | -5.44 M | -65.8 K | -186 K | 288 K | -101 K |
Betriebsaufwand |
- | - | - | 5.75 M | - | - | - | - | - | 837 K | 610 K | 258 K | 254 K |
Allgemeine und Verwaltungsausgaben |
5.03 M | 6.04 M | 4.59 M | 3.25 M | 1.97 M | 2.11 M | - | 2.66 M | 2.81 M | 837 K | 330 K | 258 K | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Panbela Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
3.13 M | 480 K | 2.91 M | 733 K | 13 K | 34.8 K | 17.1 K | 12 K | 336 K | 13.4 M | 13.3 M | 10.1 M | 9.89 M | 9.66 M | 7.89 M | 6.73 M | 6.63 M | 6.63 M | 6.01 M | 5.07 M | 5.07 M | 5.08 M | 5.06 M | 4.57 M | 3.93 M | 3.84 M | 3.67 M | 3.66 M | 3.22 M | 3.22 M | 3.2 M | 30.1 M | 29.9 M | 29.9 M | 13.6 M | 6.59 M | 6 M | 5.69 M | 5.19 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | - | - | - |
Nettogewinn |
-7.12 M | - | -7.83 M | -5.83 M | -5.11 M | - | -4.4 M | -22.1 M | -3.67 M | - | -2.14 M | -2.2 M | -2.26 M | - | -1.67 M | -419 K | -1.8 M | - | -1.37 M | -2.27 M | -1.58 M | - | -925 K | -2.49 M | -1.75 M | - | -1.22 M | -1.41 M | -5.57 M | - | -1.08 M | -978 K | -824 K | - | -793 K | -1.22 M | -2.19 M | - | -1.14 M | -57.3 K | -111 K | - | -58.2 K | -48.8 K | -48.8 K | - | 73.6 K | 92.2 K | -34 K | - | - | - | - |
Einnahmen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 36.8 K | 51.8 K | - | 34.8 K | 36.2 K | 40.2 K | - | 42.5 K | 63 K | 158 K | - | 195 K | 183 K | 67.3 K | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 142 K | 146 K | - | 142 K | 154 K | 241 K | - | 230 K | 222 K | 204 K | - | 181 K | 137 K | 168 K | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 149 K | 141 K | - | 150 K | 155 K | 1.47 K | - | 15.9 K | -3.51 K | -74 | - | 146 K | 168 K | 40.5 K | - | - | - | - |
Betriebsergebnis |
-6.73 M | - | -7.85 M | -5.88 M | -4.86 M | - | -3.62 M | -21.3 M | -4 M | - | -2.21 M | -2.23 M | -2.25 M | - | -2 M | -1.1 M | -1.07 M | - | -1.34 M | -1.09 M | -653 K | - | -917 K | -1.1 M | -1.24 M | - | -1.04 M | -1.16 M | -1.99 M | - | -1.14 M | -949 K | -975 K | - | -770 K | -1.19 M | -2.18 M | - | -1.11 M | -49.9 K | -103 K | - | -54.3 K | -43.5 K | -43.5 K | - | 82.7 K | 101 K | -26.1 K | - | - | - | - |
Zinsaufwendungen |
63 K | - | 71 K | 70 K | 102 K | - | 87 K | 16 K | 3 K | - | 2 K | 4 K | 3 K | - | 3 K | 4 K | 4 K | - | 3 K | 1.15 M | 1.03 M | - | 3 K | 1.29 M | 473 K | - | 474 K | 473 K | 199 K | - | 45 K | 45 K | 45 K | - | 38 K | 46 K | 47 K | - | 41 K | 8.85 K | 8.91 K | - | 8.91 K | 8.96 K | 8.96 K | - | 9.08 K | 9.05 K | 8.94 K | - | - | - | - |
EBITDA |
- | - | - | - | - | - | -3.62 M | -21.3 M | -4 M | - | -2.21 M | -2.23 M | -2.25 M | - | -2 M | -1.1 M | -1.07 M | - | -1.34 M | -1.09 M | -653 K | - | -917 K | -1.1 M | -1.24 M | - | -1.04 M | -1.16 M | -1.99 M | - | -1.14 M | -949 K | -975 K | - | -770 K | -1.19 M | -2.18 M | - | -1.11 M | -44.9 K | -101 K | - | -48.1 K | -39.4 K | -41.4 K | - | 86.3 K | 104 K | -26.1 K | - | - | - | - |
Betriebsaufwand |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 70.1 K | 40 K | - | - | 63.8 K | 66.6 K | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
1.2 M | - | 1.11 M | 1.64 M | 1.35 M | - | 1.29 M | 1.26 M | 1.8 M | - | 924 K | 1.24 M | 1.15 M | - | 1.22 M | 670 K | 468 K | - | 622 K | 580 K | 303 K | - | 467 K | 654 K | 658 K | - | 515 K | 487 K | 1.25 M | - | 499 K | 419 K | 481 K | - | 429 K | 585 K | 1.2 M | - | 325 K | 164 K | 48.6 K | - | 39.2 K | 21.2 K | 21.2 K | - | 32.6 K | 37.3 K | 34 K | - | - | - | - |
Alle Zahlen in USD-Währung